BoltonT. B.: Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev., 59; 606 (1979).
2.
BrindleyG.: Cavernosal alfa-blockade: a new technic for investigating and treating erectile impotence. Brit. J. Psych., 143; 332 (1983).
3.
CrosslandJ.: in: Lewis's Pharmacology, p. 823, 5th ed., Churchill Livingstone, New York1980.
4.
EckhardtC.: Untersuchungen über die Erektion des Penis beim Hunde. Beitr. Anat. Physiol., 3; 123 (1863).
5.
GibertiC., MartoranaG., DamonteP., GiulianiL.: Intracavernous administration of thymoxamine in patients with post-radical prostatectomy impotence. IRCS Med. Sci., 12; 631 (1984).
6.
HedlungH., AnderssonK. E.: Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery. J. Urol., 134; 1247 (1985).
7.
KlingeE., SjostrandN.: Comparative study of some isolated mammalian smooth muscle effectors of penile erection. Acta Physiol. Scand., 100; 354 (1977).
8.
MelmanA., HenryD.: The possible role of the catecholamines of the corpora in penile erection. J. Urol., 121; 419 (1979).
9.
MichalV.: Arterial epigastrico-cavernous anastomosis for the treatment of sexual impotence. World J. Surg., 1; 515 (1977).
10.
PochG., KukovetzR.: Papaverine: induced inhibition of phosphodiesterase activity in various mammalian tissues. Life Sciences, 10; 133 (1971).
11.
SaidS. I., MuttV.: Polypeptide with broad biological activity: Isolation from small intestine. Science, 169; 1217 (1970).
12.
ViragR.: Intracavernous injection of papaverine for erectile failure. Lancet, II; 938 (1982).
13.
ViragR.: Papaverine et impuissance.Éditions du Céri, Paris1986.
14.
WillisE., OttesenB., WagnerG., SundlerF., FahrenkrugJ.: Vasoactive intestinal polypeptide (VIP) as a possible neurotrasmitter involved in penile erection. Acta Physiol. Scand., 113; 545 (1981).
